Active in Life Science markets, the Siegfried Group is a preferred partner for development services and the production of active pharmaceutical ingredients (API), intermediates, controlled & standard substances as well as complex formulations. The ability to develop and manufacture drug substances and products by one and the same company is a compelling value proposition for our clients in the pharmaceutical industry.

Siegfried’s development and production facilities are located in Switzerland, Malta and the U.S.A. The company currently employs approximately 850 people and achieved annual sales of approx. CHF 280 million (US$ 255 million) in 2009.